In this conversation, PFCD’s Ken Thorpe and Caregiver Action Network’s CEO Marvell Adams, Jr. examine how “Most Favored Nation” drug pricing could reshape access to medicines for Medicaid beneficiaries.

They discuss the potential ripple effects on caregivers, including added burdens from restricted access or disrupted care, and consider the broader equity implications for vulnerable populations. The discussion also explores practical policy alternatives that protect affordability while preserving innovation and reliable access to lifesaving treatments.